Effective date
Medicare changes effective December 21, 2018
2 CMS and MAC policy updates take effect on this date. Every entry links to the government document it came from.
Fewer than 5 updates — this date is not listed in the index.
FDA · 2
- FDA Approval: ULTOMIRIS (RAVULIZUMAB) — Type 1 - New Molecular Entity
FDA-BLA761108NationalHematologysource ↗
- FDA Approval: INBRIJA (LEVODOPA) — Type 3 - New Dosage Form
FDA-NDA209184NationalNeurologysource ↗